Changes of Plasma Atrial and Brain Natriuretic Peptide Levels During Hemodialysis
Fuminobu Ishikura(National Cerebral and Cardiovascular Center), Kunio Miyatake(National Cerebral and Cardiovascular Center), D Shirai(Osaka Kaisei Hospital), Yung-Dae Park(Osaka Kaisei Hospital), Hiroaki Matsuoka(Social Welfare Department), Akihiro Tani(Tokushima University)
Cited by 16
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique
|Journal of the American College of Cardiology|1986|573
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307